Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 81,342 shares at $15.14 ($1.2M) on 2026-03-06, disclosed to the SEC on 2026-03-10.
Seasonal sale ($1.2M) by President and COO — this insider has traded ADPT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.14 | 30,941 | $468K | 38.7% |
| 2 | $14.79 | 30,941 | $458K | 37.8% |
| 3 | $14.68 | 19,460 | $286K | 23.6% |
| Total | $14.90 avg | 81,342 | $1.2M | 100% |
| Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |
| ADPT | SELL | 2026-04-21 | $1.0M | — | Filing → |